Active substances
Measles + Mumps + Rubella
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Priorix | 103.0,103.7,103.0 CCID50,CCID50,CCID50 | Powder and solvent for solution for injection · intramuscular, subcutaneous | 100 Vial | SAR 4550.70 | Biological · Prescription | GLAXO SAUDI ARABIA | Valid |
| PRIORIX 0.5ML VIAL | Solution for injection · Intramuscular use | 1 Vial | SAR 44.95 | Biological · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed | |
| PRIORIX-TETRA VACCINE | Solution for injection · Parenteral use | 1 Vial | SAR 212.20 | Biological · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.